China's Tianyin Pharmaceutical Receives Approval For Ofloxacin And Fleroxacin To Expand Antibiotic Product Line
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - Tianyin Pharmaceutical, a Traditional Chinese Medicine and Western drug maker in China, announced it received manufacturing licenses from China's State FDA for its antibiotic products fluoroquinolone-based ofloxacin and quinolone broad-spectrum fleroxacin